Special Award for services to the EACPT for Michael Orme

The EACPT presented a Special Award for services to the EACPT for Professor Michael Orme. 

The Award was accepted on his behalf at the 11th EACPT Congress in Geneva by EACPT co-founder Professor Folke Sjöqvist. 

Michael Orme  qualified in medicine from Cambridge University and King’s College Hospital in London in 1965. He trained in internal medicine and clinical pharmacology at the Royal Postgraduate Medical School in London and at the Karolinska Institute in Stockholm, Sweden. He was appointed as senior lecturer in clinical pharmacology at Liverpool University Medical School in 1975 and was promoted to a personal chair in 1984. He was Dean of the Faculty of Medicine in Liverpool from 1991- 1996.  

He co-edited the 2012 manifesto from WHO, CIOMS and IUPHAR on Clinical Pharmacology in Health Care, Teaching and Research. 

He worked with European clinical pharmacology colleagues in the late nineteen eighties to develop a European approach through the WHO European office in Copenhagen. This led to a meeting in Verona, Italy in 1993 to found the European Association for Clinical Pharmacology and Therapeutics (EACPT). Michael was the first honorary secretary of EACPT from 1995-1999 and he was re-elected to this post for 1999-2003. He was also chairman of the Education Sub-committee of EACPT from 1997 to 2003.  He was elected chairman of EACPT for the period 2003-2007 and remained on the Executive Committee of EACPT as past chairman until 2011. 

In these roles Michael Orme brought his interests in European and global efforts of clinical pharmacology as a medical speciality devoted to the rational use of drugs, to growing EACPT into a major international organisation representing all clinical pharmacology societies in Europe.  

The Special Award was presented at the 11th EACPT Congress in Geneva 28th - 31st August 2013. 

The EACPT was founded 20 years ago and now includes all national organisations for clinical pharmacology in Europe. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Official EACPT journal: Clinical Therapeutics 

More about the 11th EACPT Congress in Geneva.

More about the EACPT. 

2013 EACPT Scientific Award for new treatment approach for Parkinson's disease

The EACPT is delighted to announce that the 2013 EACPT Scientific Award goes to Dr David Devos from the Department of Medical Pharmacology at the Université Lille Nord de France. The EACPT Scientific Award is for the report by Dr Devos about a new approach to treating Parkinson's disease. 

The paper, for which Dr Devos was corresponding author, was published in the July 2012 issue of

Dr David Devos

the high impact international journal -  Lancet Neurology, entitled:

'Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.'

The prize, which includes a 2000 € award, will be presented to Dr Devos at the 11th EACPT Congress in Geneva 28th - 31st August 2013.

David Devos obtained his Doctor of Neurology and Doctor of Neuroscience degrees from the University of Lille, France. Between 2002 and 2010, he worked as a hospital physician in the Department of Neurology of the Centre Hospitalier Universitaire of Lille, where he is now associate professor in medical pharmacology (Lille Nord de France University, EA1046/EA4559).
 His main research interest is in developing new symptomatic and disease-modifying strategies in neurodegenerative diseases, such as Parkinson’s disease, amyotrophic lateral sclerosis, dementia and cerebellar ataxia. His researches are mainly based upon clinical trials but also include preclinical, translational and clinical studies in neuropsychopharmacology.

The EACPT Scientific Award is for the best scientific paper on a topic relevant to clinical pharmacology and therapeutics published by a European clinical pharmacologist over the period between EACPT congresses, based on nominations by the EACPT Council. The award has a value of 2000 €. Criteria are scientific quality, broader impact in science, and the importance of the work in the context of healthcare delivery.

The EACPT was founded 20 years ago and now includes all national organisations for clinical pharmacology in Europe. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Official EACPT journal: Clinical Therapeutics 

More about the 11th EACPT Congress in Geneva.

More about the EACPT.